CT-15300

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameCT-15300
Drug Alias NameCT-15300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDongguan Dongguan Sunshine Pharmaceutical Research and Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDongguan Dongguan Sunshine Pharmaceutical Research and Development Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A